CombiMatrix Corp (CBMX.O)
CBMX.O on Consolidated Issue listed on NASDAQ Capital Market
3.32USD
17 May 2013
3.32USD
17 May 2013
Price Change (% chg)
$0.01 (+0.30%)
$0.01 (+0.30%)
Prev Close
$3.31
$3.31
Open
$3.36
$3.36
Day's High
$3.36
$3.36
Day's Low
$3.24
$3.24
Volume
92,372
92,372
Avg. Vol
789,733
789,733
52-wk High
$14.14
$14.14
52-wk Low
$1.40
$1.40
About
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based... (more)
No analyst recommendations are available for CBMX.O.
Overall
| Beta: | 0.24 |
| Market Cap (Mil.): | $11.91 |
| Shares Outstanding (Mil.): | 3.59 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBMX.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 27.85 | 35.83 |
| EPS (TTM): | -8.75 | -- | -- |
| ROI: | -243.35 | 6.71 | 18.72 |
| ROE: | -292.05 | 8.56 | 19.54 |
Competitors
| Price | Change | |
|---|---|---|
| Becton, Dickinson and Co. (BDX.N) | $101.78 | +1.28 |
| Illumina, Inc. (ILMN.OQ) | $72.00 | +2.35 |
| Sequenom, Inc. (SQNM.OQ) | $4.10 | -0.01 |
| Nanogen, Inc. (NGEN.PK) | $0.01 | -0.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

